Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients

Transplantation

Volumn 87, Issue 9, 2009, Pages 1372-1376

  Hardinger, Karen L ^a   Brennan, Daniel C ^b   Schnitzler, Mark A ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basiliximab; ECD kidneys; Thymoglobulin

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR SELECTION; EXPANDED CRITERIA DONOR; EXTENDED DONOR RECIPIENT; HUMAN; HUMAN TISSUE; HYPERTENSIVE DONOR KIDNEY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANIMALS; ANTILYMPHOCYTE SERUM; BLOOD PRESSURE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATIENT SELECTION; RABBITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 67649586613     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a2475f     Document Type: Article

References (7)

1. Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002; 2: 701.
2. Whiting JF, Woodward RS, Zavala EY, et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: Analysis of Medicare payments. Transplantation 2000; 70: 755.
3. Lebranchu Y, Bridoux F, Buchler M, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant2002; 2: 48.
4. Mourad G, Rostaing L, Legendre C, et al. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation2004; 78: 584.
5. Brennan DC, Daller JA, Lake KD, et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967.
6. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant2008; 8: 753.
7. Ojo AO, Leichtman AB, Punch JD, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36: 153.